Lessons in Laboratory Compliance from a $30 Million Settlement
‘Lean lab’ setup appears to have caught the eyes of investigators
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
‘Lean lab’ setup appears to have caught the eyes of investigators
Robin Divine, MBA, president and CEO of TriCore Reference Laboratories, discusses key recent developments in the lab industry and predictions for 2024.
Comments on the FDA’s proposed rule to regulate LDTs as in vitro diagnostic devices reveal mixed reactions.
Genialis CEO and co-founder Rafael Rosengarten, PhD, discusses key 2023 AI developments and what they could mean for laboratories.
First marketing authorization of a blood test assessing genetic variants related to cancer opens the door for clearance of similar tests.
Lisa-Jean Clifford of Gestalt Diagnostics, discusses key trends, challenges, and solutions in data analytics for clinical labs.
While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
How lab leaders can manage the data security risks of staff using personal devices for work-related purposes.
This BYOD policy template illustrates the basic issues lab leaders may want to address to ensure cybersecurity in their facilities.
An overview of likely lab audit targets for the coming year, and how laboratories can ensure they’re prepared.